Main > INFECTIOUS DISEASES > Ehrlichiosis > Granulocytic Ehrlichiosis > Diagnostics

Product USA. A

PATENT ASSIGNEE'S COUNTRY USA
UPDATE 11.99
PATENT ASSIGNEE This data is not available for free
PATENT CLAIMS Method of continually growing human granulocytic Ehrlichia, E. equi, or E. phagocytophila comprising
- Infecting a cell line, wherein the phenotype of the cell line
is selected from the group consisting of a promelocytic
leukemia cell line, an acute myelogenous leukemia cell li
ne, a histiocytic lymphoma cell line, an acute monocytic
leukemia cell line, & an embryonic lung cell line, with human
granulocytic Ehrlichia, E. equi, or E. phagocylophila by co-
culturing the cell line with blood cells infected with human
granulocytic Ehrlichia, E. equi, or E. phagocytophila within
suitable culture medium
- Culturing the infected cell line with fresh uninfected cultured
cells
- Splitting the infected cell line in a split ratio of 1:2-1:3 of
infected cells to additional said fresh uninfected cultured
cells in order to maintain the culture
- Identifying a cytopathic effect on the infected cell line,
wherein the means for identifying the said effect comprise
(i) Using an immunofluorescence assay, Western blot
analysis, EIA or RIA to detect the presence of human granu
locytic Ehrlichia, E. equi or E. phagocytophila using detec
tor Ab specific for said human granulocytic Ehrlichia, E.
equi or E. phagocytophila; (ii) Using PCR or RFLP to con
firm the presence or absence of human granulocytic Ehrli
chia, E. equi or E. phagocytophila in the cell lines with a
primer or a 16S rDNA gene specific for said human granulo
cytic Ehrlichia, E. equi or E. phagocytophila; or (iii) Obser
ving degenerative cell morphology by light microscopy
PATENT PHOTOCOPY Available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back